Deciphering lung adenocarcinoma prognosis and immunotherapy response through an AI ‐driven stemness‐related gene signature
Journal of Cellular and Molecular Medicine · 2024-07 · 28 (14)
DOI: 10.1111/jcmm.18564 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 24.07.2024. Verfasst von Bicheng Ye und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Yangzhou Polytechnic College, Yangzhou, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Immunotherapy, Gene Expression Regulation, Neoplastic, Lung Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yangzhou Polytechnic CollegeYangzhou Polytechnic College University-Level Key.
Abstract (Originalsprache)
Lung adenocarcinoma (LUAD) is a leading cause of cancer‐related deaths, and improving prognostic accuracy is vital for personalised treatment approaches, especially in the context of immunotherapy. In this study, we constructed an artificial intelligence (AI)‐driven stemness‐related gene signature (SRS) that deciphered LUAD prognosis and immunotherapy response. CytoTRACE analysis of single‐cell RNA sequencing data identified genes associated with stemness in LUAD epithelial cells. An AI network integrating traditional regression, machine learning, and deep learning algorithms constructed the SRS based on genes associated with stemness. Subsequently, we conducted a comprehensive exploration of the connection between SRS and both intrinsic and extrinsic immune environments using multi‐omics data. Experimental validation through siRNA knockdown in LUAD cell lines, followed by assessments of proliferation, migration, and invasion, confirmed the functional role of CKS1B, a top SRS gene. The SRS demonstrated high precision in predicting LUAD prognosis and likelihood of benefiting from immunotherapy. High‐risk groups classified by the SRS exhibited decreased immunogenicity and reduced immune cell infiltration, indicating challenges for immunotherapy. Conversely, in vitro experiments revealed CKS1B knockdown significantly impaired aggressive cancer phenotypes like proliferation, migration, and invasion of LUAD cells, highlighting its pivotal role. These results underscore a close association between stemness and tumour immunity, offering predictive insights into the immune landscape and immunotherapy responses in LUAD. The newly established SRS holds promise as a valuable tool for selecting LUAD populations likely to benefit from future clinical stratification efforts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Clinical Medicine, Yangzhou Polytechnic College, Yangzhou, China.
- Department of Respiratory and Critical Care Medicine, Huai'an Hospital Affiliated to Yangzhou University (The Fifth People's Hospital of Huai'an), Huai'an, China.
- Huai'an Second People's Hospital Affiliated to Xuzhou Medical University, Huai'an, Jiangsu, China.
- Department of Nursing, Jiangsu Vocational College of Medicine, Yancheng, China.
- Department of Urology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
- Department of Oncology, Shuyang County Hospital of Traditional Chinese Medicine, Suqian, China.
ORCID-Profile: Wen Zhuang, Cheng Chen, Aimin Jiang
Förderung
- Yangzhou Polytechnic CollegeYangzhou Polytechnic College University-Level Key
Zitieren
APA
Ye, B., Hongting, G., Zhuang, W., Chen, C., Yi, S., Tang, X., Jiang, A., & Zhong, Y. (2024). Deciphering lung adenocarcinoma prognosis and immunotherapy response through an AI ‐driven stemness‐related gene signature. Journal of Cellular and Molecular Medicine, 28(14). https://doi.org/10.1111/jcmm.18564
Vancouver
Ye B, Hongting G, Zhuang W, Chen C, Yi S, Tang X, et al. Deciphering lung adenocarcinoma prognosis and immunotherapy response through an AI ‐driven stemness‐related gene signature. Journal of Cellular and Molecular Medicine. 2024;28(14). doi:10.1111/jcmm.18564
BibTeX
@article{Ye2024,
author = {Ye, Bicheng and Hongting, Ge and Zhuang, Wen and Chen, Cheng and Yi, Shulin and Tang, Xinyan and Jiang, Aimin and Zhong, Yating},
title = {Deciphering lung adenocarcinoma prognosis and immunotherapy response through an AI ‐driven stemness‐related gene signature},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {14},
doi = {10.1111/jcmm.18564}
}
EUVIMED